Gen Zer Films Himself Every Day—Then Uncovers a Shocking Truth
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A teenager has shared how he noticed the first symptom that led to his cancer diagnosis—by watching his own videos back.
Felipe, 19, from Georgia, had recently moved to college in Oregon when he decided to take part in a viral health craze on TikTok. The Coconut Cult trend involves people documenting their daily intake of probiotic yogurt on TikTok and Instagram. But what he noticed watching back his videos wasn't digestive benefits—it was a lump forming in his neck.
"I took the daily videos after seeing the craze with Coconut Cult and wanted to see any results from its daily intake," Felipe told Newsweek. "I noticed something was wrong after the left side of my neck appeared swollen; I saw it was curvy on the video, and then that's when I felt the bump."
Pictures from the TikTok video that prompted Felipe to visit the emergency room.
Pictures from the TikTok video that prompted Felipe to visit the emergency room.
@felipedkl2/TikTok
Concerned, Felipe sought medical attention, initially receiving a suspected diagnosis of bacterial infections like strep throat or mononucleosis. But doctors recommended a biopsy to be sure.
"The ER had initially told me they suspected bacterial infections like strep throat or mononucleosis," Felipe said. "They immediately recommended a biopsy to see what's causing them to be inflamed."
When that result came back, it wasn't what anyone was expecting—Felipe was diagnosed with Hodgkin's lymphoma, a type of cancer.
What Is Hodgkin's Lymphoma?
"Lymphoma is a cancer of the lymph glands, and if the lymph glands contain specific characteristic cells, they fall under the category of Hodgkin's lymphoma," Dr. Siddhartha Ganguly, section chief of hematology at Houston Methodist and an academic professor for Weill Cornell Medical College, told Newsweek. "It is relatively rare. There are only about 8,000 to 8,500 new cases across the country a year."
Thankfully, when caught quickly, it is very treatable. "If we catch Hodgkin's lymphoma in the early stage of the disease, then the cure rate reaches as high as 95 percent to 98 percent in young Hodgkin's patients," Ganguly said.
Felipe, who didn't share his surname, posted the video that prompted him to get checked out on TikTok where it now has over 722,000 views.
Ganguly said the symptoms of Hodgkin's lymphoma you should look out for: "If somebody has enlargement of a gland, whether they have symptoms of unintentional weight loss, night sweats or fever, and the gland is present for more than seven to 10 days, see your primary care physician," he said.
"They may prescribe an antibiotic to make sure it's not an infection. If it is still there after that antibiotic, make an appointment to see a hematologist who deals with lymphoma. The only way to make a diagnosis is through a biopsy."
For Felipe, the next steps include a PET scan and chemotherapy sessions with the lymphoma medical team. He has continued to share parts of his journey on TikTok and remains positive, and is thankful for the support from viewers.
"I feel better now that I have an answer. I'm taking things day by day," he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
13 minutes ago
- Newsweek
Boy, 4, With Cancer Deported by ICE Despite Being US Citizen, Lawsuit Says
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A federal lawsuit filed in Louisiana alleges that U.S. Immigration and Customs Enforcement (ICE) deported a 4-year-old U.S. citizen boy with stage IV kidney cancer, along with his mother and sibling, to Honduras in April 2025. The complaint contends that the deportation occurred without adequate notice, legal counsel, or arrangements for the child's ongoing medical care. Why It Matters Immigration authorities have been under heightened scrutiny amid allegations of misconduct, with the agency at the center of the national debate over immigration policy. That spotlight has widened since President Donald Trump ordered a ramp-up in arrests to fulfill his pledge of mass deportations, prompting renewed questions about the legality and human impact of ICE's enforcement practices. What To Know Though they are U.S. citizens and were born in Louisiana, the boy and his 7-year-old sister were deported to Honduras along with their 25-year-old mother, who is a Honduran citizen, on April 25, according to a federal lawsuit filed in the Middle District of Louisiana on July 31. The filing uses pseudonyms for the family, referring to the brother and sister as "Romeo" and "Ruby" and their mother as "Rosario." Before their deportations, Romeo, now 5, was receiving "life-saving" treatment at a New Orleans children's hospital for his "rare and aggressive form" of cancer, following his diagnosis at age 2, a complaint says. "It has been scary and overwhelming," Rosario said in a press release on July 31. "As a direct consequence of ICE's unlawful conduct, Romeo was deprived of much-needed continuity in his treatment, and he has faced substantial health risks due to his inability to access emergency specialized care and the routine critical oncological care that was available to him in the United States," the family's attorneys wrote in court documents. According to court documents, the family was detained during a routine ICE check-in and later transported to an airport for deportation. The complaint states that the mother was not informed that her attorney was attempting to contact her, nor that her husband was seeking custody of their U.S. citizen daughter. Court filings also allege that the family was held in a van for approximately five hours without communication and later returned to a hotel, still without the ability to contact anyone outside their immediate environment. The complaint asserts that the deportations were executed without providing the family an opportunity to arrange for the care of the children, including the young boy undergoing treatment for advanced kidney cancer. File photo: Agents wait to detain migrants coming for their hearings at an immigration court in New York. File photo: Agents wait to detain migrants coming for their hearings at an immigration court in New York. Andrea Renault/STAR MAX/IPx The lawsuit is being brought by the National Immigration Project, Gibson Dunn, Most & Associates, and Ware Immigration on behalf of Romeo's family and a second family who, according to the filing, were deported by ICE under similar circumstances on April 25. The second family is identified in court documents as including "Julia," a 30-year-old mother from Honduras, and her two daughters, "Jade," age 2, a U.S. citizen born in Baton Rouge, and "Janelle," age 11, a Honduran citizen. All names in the filing are pseudonyms. The lawsuit alleges that ICE did not give Rosario or Julia the opportunity to decide whether their children would accompany them to Honduras or remain in the United States with other family members. "The media and Democrat politicians are force-feeding the public false information that U.S. citizen children are being deported," Tricia McLaughlin, a spokesperson for the Department of Homeland Security, told Newsweek. "This is false and irresponsible. Rather than separate their families, ICE asked the mothers if they wanted to be removed with their children or if they wanted ICE to place the children with someone safe the parent designates. The parents in this instance made the determination to take their children with them back to Honduras," she said. "Further, when there is an underlying health issue, ICE makes sure that treatment is available in the country to which the illegal alien is being removed. The implication that ICE would deny a child the medical care they need is flatly FALSE, and it is an insult to the men and women of federal law enforcement. ICE ALWAYS prioritizes the health, safety, and well-being of all detainees in its care," she added. The lawsuit, J.L.V. v. Acuna, filed in the U.S. District Court for the Middle District of Louisiana, names Attorney General Pam Bondi, the Department of Homeland Security, DHS Secretary Kristi Noem, ICE and ICE Director Todd Lyons, as well as New Orleans ICE Field Office Director Brian Acuna, Assistant Field Office Director Scott Ladwig, and the office's former director, Mellissa Harper, as defendants. The lawsuit requests the immediate return of the family to the United States, as well as recognition of their legal rights and compensation for damages. Media reports note some discrepancies in the boy's age. While several outlets have referred to him as 5, court documents list him as 4 years old at the time of deportation. What People Are Saying DHS Assistant Secretary Tricia McLaughlin: "DHS takes its responsibility to protect children seriously and will continue to work with federal law enforcement to ensure that children are safe and protected. Parents, who are here illegally, can take control of their departure. Through the CBP Home App—the Trump Administration is giving parents illegally in the country a chance to take full control of their departure and self-deport, with the potential ability to return the legal, right way and come back to live the American dream. It is free and available for all mobile devices." National Immigration Project attorney Stephanie Alvarez-Jones told McClatchy News: "ICE put these families through a series of incredibly traumatizing experiences, taking actions that are completely shocking from a human perspective and illegal even by ICE's own standards." Rosario said in a press release: "After so many years in the United States, it has been devastating to be sent to Honduras. Life in Honduras is incredibly hard. I don't have the resources to care for my children the way they need. Since returning, my daughter has gotten sick and struggled with anxiety, and I've been struggling with my own health issues too. I was diagnosed with high anxiety and prescribed medication for stress. It's not the same as living in your own country. It's been painful every step of the way." Sirine Shebaya, Executive Director of the National Immigration Project, said in a press release: "ICE's actions in this case are not only unlawful, they are cruel and show a complete disregard for family values and the well-being of children." Court documents read: "Romeo needs regular specialized care and follow-up treatment to this day." What Happens Next The families are requesting compensation in an unspecified amount and have called for the case to be heard before a jury.
Newsweek
13 minutes ago
- Newsweek
Woman Desperate for Diagnosis for Years—Then Notices Ear Looks Different
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. For a decade, Holli Barron went in and out of doctor's offices, desperate for answers to a growing list of mysterious symptoms—throat swelling, rashes, extreme fatigue, and more. Despite receiving multiple diagnoses over the years, no treatment brought relief, leaving her feeling as if she was locked in a battle she couldn't win. That changed recently when she developed a new and unusual symptom: red, hot ear cartilage. It led to the correct diagnosis—relapsing polychondritis—a rare condition that causes repeated episodes of swelling and inflammation in cartilage and other tissues throughout the body, affecting fewer than 5,000 people in the U.S. Barron shared her experience in a TikTok video (@therapyandthings) that has been viewed over 526,000 times. She wrote: "When you send your rheumatologist a photo of 1 new weird symptom and suddenly after YEARS of no diagnosis you're getting seen by two specialists." She added that she underwent multiple tests and two CT scans in just 48 hours. "Living with a rare autoimmune disease also takes an emotional toll," the South Carolina mom told Newsweek. "Going years without a diagnosis can be difficult," Barron added, stressing the importance of caring for the mind, body, and soul, while navigating chronic illness. Two screenshots from the viral video showing Holli Barron looking puzzled and shocked. Two screenshots from the viral video showing Holli Barron looking puzzled and shocked. TikTok/@therapyandthings Sharing Her Story Online The licensed mental-health counselor later posted another video featuring photos of her ears. She warned viewers not to panic if they experience redness, as it was just one of many symptoms she had. "Prior to the ear redness and pain," Barron said, "including inflammatory arthritis, Raynaud's Phenomenon, tinnitus, episodes of minor vertigo, extreme fatigue, sensation of throat swelling, pain on the bridge of my nose. "Following CT scans, it was determined that I also have calcifications in the cartilage of my trachea," she added. The cartilage of Barron's ear is red and the lobe is the usual color. The cartilage of Barron's ear is red and the lobe is the usual color. Holli Barron Understanding Relapsing Polychondritis The Genetic and Rare Diseases (GARD) Information Center says relapsing polychondritis (RP) can also affect the airways (trachea), rib cartilage, eyes, heart, blood vessels, skin, kidneys, and nervous system. Signs and symptoms vary widely between individuals, depending on the areas involved. The exact cause is unknown, though both genetic influences and unidentified factors are believed to play a role. RP often occurs alongside autoimmune disorders. "Autoimmune disease symptoms can tend to overlap," Barron said. "So I don't want to say I was 'misdiagnosed,' but it did take many years to land at this correct diagnosis. Some previous diagnoses I was told included seronegative rheumatoid arthritis, lupus-like illness, tendinitis, and inflammatory arthritis." Living with an autoimmune disease while juggling mom life, a Ph.D., and work can be "challenging," Barron said—especially during flare-ups. "The fatigue and pain can be debilitating at times, making everyday tasks more difficult to complete," she added. How Is Relapsing Polychondritis Treated? Since only around 5 percent of rare diseases have FDA-approved treatments, finding a health-care team that can effectively manage symptoms and overall well-being is critical. People with rare diseases often face delayed diagnoses, limited treatment options, and difficulty finding providers with the necessary expertise. Building a care team that understands the patient's needs can greatly improve quality of life. For now, Barron will continue taking hydroxychloroquine, a disease-modifying antirheumatic drug (DMARD) that can reduce the pain of arthritis and swelling and prevent joint damage. "I will also be adding an immunosuppressant medication called Enbrel to hopefully slow the progression of the disease," Barron said. Is there a health issue that's worrying you? Let us know via health@ We can ask experts for advice, and your story could be featured on Newsweek.
Newsweek
43 minutes ago
- Newsweek
Opioids: Parasitic Worm Discovery Could Lead to Safer Painkillers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The evolutionary trick of parasitic worm that sneakily burrows into the skin of its victims could provide new alternatives to opioid-based pain treatments. Opioids are currently used to treat moderate to severe pain, as well coughing and diarrhea. Although they can provide effective relief, long-term use can also lead to dependence, with negative physical and mental health consequences. Researchers discovered that the worm—Schistosoma mansoni—suppresses neurons in the skin to evade detection in a mechanism likely developed to enhance its own survival. The molecules responsible for this suppression of sensation could help in the development of new painkillers, according to the team at the Tulane School of Medicine. Schistosomiasis is a parasitic infection caused by helminths, a type of worm known to survive in their mammal hosts for many years. Their larvae can infest freshwater bodies like lakes, ponds and rivers—infecting people who, for example, swim, fish or wash clothes in the water. "While bacteria often cause painful cutaneous reactions, host skin invasion by the human parasitic helminth Schistosoma mansoni often goes unnoticed," the researchers wrote in their paper. Medical microscopy showing parasite. Medical microscopy showing parasite. defun/Getty Images S. mansoni often evades detection by the immune system, unlike other bacteria or parasites that cause pain, itching or rashes—a feat the team set out to investigate. After conducting experiments on mice, the researchers found that S. mansoni produces molecules that suppress the activity of TRPV1+, a protein used to send signals that the brain interprets as heat, itching or pain. As part of the pain-sensing process in sensory neurons, TRPV1+ regulates immune responses in scenarios including allergy, autoimmunity, cancer, infection and even hair growth, the researchers explained. It is likely the parasitic worm evolved its ability to block TRPV1+ because it enhance its survival, the researchers said. "If we identify and isolate the molecules used by helminths to block TRPV1+ activation, it may present a novel alternative to current opioid-based treatments for reducing pain," said paper author and immunologist professor De'Broski R. Herbert| in a statement. "The molecules that block TRPV1+ could also be developed into therapeutics that reduce disease severity for individuals suffering from painful inflammatory conditions." Open spillage bottle of opioid pain killing tablets. Open spillage bottle of opioid pain killing tablets. BackyardProduction/Getty Images The study also revealed that TRPV1+ is necessary for initiating host protection against S. mansoni. Activation of the protein leads to rapid mobilization of immune cells, including gd T cells, monocytes and neutrophils, which induce inflammation. This inflammation, the researchers explained, plays a crucial role in host resistance to the larval entry into the skin. These findings highlight the importance of neurons that sense pain and itching in successful immune responses. "Identifying the molecules in S. mansoni that block TRPV1+ could inform preventive treatments for schistosomiasis. We envision a topical agent which activates TRPV1+ to prevent infection from contaminated water for individuals at risk of acquiring S. mansoni," said Herbert. In the study, mice were infected with S. mansoni and evaluated for their sensitivity to pain as well as the role of TRPV1+ in preventing infection. "S. mansoni infection significantly reduced thermal pain sensitivity evoked by TRPV1+ neurons. Consistently, isolated skin sensory neurons from infected mice had significantly reduced calcium influx and neuropeptide [chemical messenger] release in response to the TRPV1 agonist capsaicin [an irritant for humans and mammals] compared to neurons from naïve controls," the study authors wrote. "Using gain-and loss-of-function approaches to test whether TRPV1+ neurons initiate host-protective responses revealed that TRPV1+ neurons limit S. mansoni skin entry and migration into the pulmonary tract." The researchers are now planning to identify the nature of the secreted or surface-associated helminth molecules that are responsible for blocking TRPV1+ activity and specific gd T cell subsets that are responsible for immune responses. They also seek to further understand the neurons that helminths have evolved to suppress. Newsweek has reached out to the researchers for additional comment. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about opioids? Let us know via health@ Reference Inclan-Rico, J. M., Stephenson, A., Napuri, C. M., Rossi, H. L., Hung, L.-Y., Pastore, C. F., Luo, W., & Herbert, D. R. (2025). TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni. The Journal of Immunology.
